Adding intravenous thrombolysis to endovascular treatment is not associated with an increased risk for bleeding or with changes in functional outcomes in patients with carotid tandem lesions.

Germany: A recent systematic review and meta-analysis published in Nature Medicine highlighted the benefits of intravenous (IV) iron therapy for patients with heart failure (HF) and iron deficiency.

Inebilizumab-cdon was previously approved by the FDA for neuromyelitis optica spectrum disorder (NMOSD) in adults who are ...

Dr. Rashmi Gulati, MD, Board Certifed in Internal Medicine Dr. Sturat Weg, MD Ozone Therapy Physician Patients Medical Staff ...

A multidisciplinary clinical team led by Professor Bernat Soria from the Institute of Bioengineering at the Miguel Hernández University of Elche (UMH ...

This innovative injection was developed and produced by Belief BioMed, while Takeda China is responsible for its ...

Phase 3 IFT Study results presented at AAN 2024 show that IV fosphenytoin provides fast, significant pain relief for acute ...

From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron supplementation was found to be safe but resulted in mixed findings, according to a ...

Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients ...